Using both parental and shBrca1 knockdown MDA-MB-231 cells, we demonstrated that overexpression of FGFR2 could dramatically promote tumor cell growth and activate downstream targets, illustrating the oncogenic role of FGFR2 and its related signaling in breast cancers regardless of BRCA1 status. Here, FGFR2 is linked to breast cancer.